Vesalius Cardiovascular
PrivateLast Round
Grant
May 4, 2023
Total Funding Raised
$61,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vesalius Cardiovascular is a medical device company that develops non-invasive transfemoral mitral valve repair solutions for the treatment of degenerative mitral regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vesalius Cardiovascular Comparables
Compare Vesalius Cardiovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CoreMedic | 87% | |
| NeoChord | 83% | |
| 4C Medical Technologies, Inc. | 82% |
Vesalius Cardiovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 4, 2023 | ||||
| Grant | Apr 1, 2020 |
Key People
Founding team and executive leadership
Vesalius Cardiovascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
| entrepreneurship@UBC | Accelerator |
| National Research Council of Canada | Grant |
| HATCH Venture Builder | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 2112% MoM, reaching 1.3K.
- Jan 2, 2026
Monthly visitors grew 98% MoM, reaching 1.3K.
Vesalius Cardiovascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vesalius Cardiovascular's valuation, stock price, and market status.
Is Vesalius Cardiovascular a public or private company?
Vesalius Cardiovascular is a private company.
What is the current stock price of Vesalius Cardiovascular?
Vesalius Cardiovascular is a private company with no public stock price. No recent secondary market data is available.
How much is Vesalius Cardiovascular worth (valuation)?
Valuation information for Vesalius Cardiovascular is not publicly available.
Can I buy Vesalius Cardiovascular stock?
Vesalius Cardiovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vesalius Cardiovascular's last funding round?
Vesalius Cardiovascular's most recent funding round was Grant on May 4, 2023.
Who are the main investors in Vesalius Cardiovascular?
Key investors in Vesalius Cardiovascular include Creative Destruction Lab, entrepreneurship@UBC, National Research Council of Canada, HATCH Venture Builder.
Will Vesalius Cardiovascular IPO soon?
No public IPO plans have been announced for Vesalius Cardiovascular.
How can I track Vesalius Cardiovascular secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vesalius Cardiovascular's secondary market activity and sign up for updates.